
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City
Author(s) -
Ashly E. Jordan,
Charles M. Cleland,
Katarzyna Wyka,
Bruce R. Schackman,
David C. Perlman,
Denis Nash
Publication year - 2020
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz659
Subject(s) - incidence (geometry) , medicine , hepatitis c virus , seroconversion , cohort , hepatitis c , methadone , immunology , virus , anesthesia , physics , optics
Hepatitis C virus (HCV) incidence has increased in the worsening opioid epidemic. We examined the HCV preventive efficacy of medication-assisted treatment (MAT), and geographic variation in HCV community viral load (CVL) and its association with HCV incidence.